FDA approves Teva's generic version of Aciphex

02/22/2007 | Globes (Israel)

The FDA approved Teva Pharmaceutical Industries Ltd.'s generic version of Aciphex, an acid pump inhibitor made by Japan's Eisai Co. Ltd., a product with annual sales of $1.3 billion. A suit by Eisai against Teva over the drug's patent is pending in federal court in New York.

View Full Article in:

Globes (Israel)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN